E Sato, F Mori, S Igarashi, T Abiko, M Takeda, S … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Corneal autofluorescence was measured in 26 eyes
of 26 patients with type 2 diabetes (mean age 57.0 years; mean disease duration 12.2 years;
mean HbA 1c 7.1%) and 13 eyes of 13 healthy age-matched control subjects (mean age ... Cited by 32 - Related articles - BL Direct - All 5 versions
AM McDermott, TL Xiao, TS Kern, CJ … - Optometry (St. Louis, Mo.), 2003 - ncbi.nlm.nih.gov BACKGROUND: Diabetic keratopathy manifests as persistent and recurrent erosions and delayed
wound healing. To investigate the role of non-enzymatic glycation of proteins in the pathogenesis
of diabetic keratopathy, we studied the presence of advanced glycation end products in ... Cited by 15 - Related articles - BL Direct - All 3 versions
- ►iovs.org Y Kaji, T Usui, T Oshika, M Matsubara, H Yamashita, … - … ophthalmology & visual …, 2000 - ARVO METHODS. An anti-AGE monoclonal antibody (6D12), which recognizes a N -carboxymethyl
lysine (CML)–protein adduct as an epitope, was prepared. Immunohistochemical localization
of CML was examined in human age-matched diabetic and nondiabetic corneas (8 of ... Cited by 58 - Related articles - BL Direct - All 5 versions
M Yamaguchi, N Nakamura, K Nakano, Y … - Diabetic …, 1998 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 20 - Related articles - BL Direct - All 3 versions
Z Wagner… - American Journal of Kidney Diseases, 2001 - Elsevier Advanced glycation end products (AGEs) such as N [epsi ] -(carboxymethyl)lysine (CML) have
been implicated in the development and progression of diabetic nephropathy. The aim of the
present study is to investigate AGE levels in patients with type 2 diabetes with special ... Cited by 48 - Related articles - BL Direct - All 4 versions
- ►pasteur.ac.ir [PDF] G Assero, G Lupo, CD Anfuso, N Ragusa, M … - BBA-Molecular and Cell …, 2001 - Elsevier In the present study, we investigated the possible role of oxidative stress and the modulation
of phospholipid turnover in two related models of pericyte injury, ie, treatment with high glucose
or advanced glycation end products (AGEs). Growing microcapillary pericytes from ... Cited by 8 - Related articles - All 5 versions
Y Kaji, S Amano, T Usui, K Suzuki, S … - Current Eye …, 2001 - informahealthcare.com Methods.An anti-AGEs monoclonal antibody (6D12), which recognizes a Ne-carboxymethyl lysine
(CML)-protein adduct as an epitope, was used for immunohistochemistry and enzyme-linked
immunosorbent assay (ELISA). Fresh bovine Descemet's membrane was incubated for 4 ... Cited by 19 - Related articles - BL Direct - All 6 versions
U Rehany, Y Ishii, M Lahav, S Rumelt - Cornea, 2000 - journals.lww.com Diabetes mellitus is known to affect multiple ocular structures. Most studies focused on the diabetic
retinopathy, some on corneal epithelium and its basement membrane, and only few on the
cor- neal endothelium and Descemet's membrane. Among the described corneal findings ... Cited by 32 - Related articles - BL Direct - All 2 versions
- ►asnjournals.org [PDF] S Sugiyama, T Miyata, Y Ueda, H Tanaka, K … - Journal of the American …, 1998 - Am Soc Nephrol Page 1. J Am Soc Nephrol 9: 1681-1688, 1998 Plasma Levels of Pentosidine in Diabetic Patients:
An Advanced Glycation End Product SATOSHI SUGIYAMA,* TOSHIO MIYATA, YASUHIKO
UEDA,t HIROSHI TANAKA,* KENJI MAEDA,t SHIROU KAWASHIMA, ... Cited by 58 - Related articles - BL Direct - All 5 versions
[CITATION] Molecular identity and cellular distribution of advanced glycation endproduct …
